Drug Trial Radar · NCT05990192
SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
42
Planned (sponsor's estimate)
Start
Jun 20, 2024
Primary completion
Dec 31, 2027
Study completion Dec 31, 2027
Sponsor
- Lead sponsor
- Institute of Cancer Research, United KingdomAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Royal Marsden NHS Foundation Trust
- First posted
- Aug 14, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
SOPRANO is a multi-centre phase II trial designed to assess the impact of SBRT with or without continuing treatment with a PARP inhibitor (PARPi) for patients with oligometastatic or oligoprogressive ovarian, fallopian tube and primary peritoneal carcinoma. SOPRANO will also establish the feasibility and acceptability of delivering SBRT in this setting.
Conditions
- Ovarian Cancer Recurrent
Interventions
Niraparib oral capsuleDrug
Niraparib used following SBRT treatment until disease progression
SBRTRadiation
SBRT may be delivered using a specialist SBRT platform, such as CyberKnife or with a linear accelerator with SBRT capabilities.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression free survivalTime frame: The primary timepoint of most interest for PFS is at six months after trial entry
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
The Royal Marsden NHS Foundation Trust
London, United Kingdom · Recruiting
Southampton General Hospital
Southampton, United Kingdom · Recruiting
St James's University Hospital
Leeds, Leeds, United Kingdom · Recruiting
Leicester Royal Infirmary
Leicester, Leicester, United Kingdom · Recruiting
The Christie NHS Foundation Trust
Manchester, Manchester, United Kingdom · Recruiting
Western General Hospital
Edinburgh, Scotland, United Kingdom · Recruiting
The Royal Marsden NHS Foundation Trust
Sutton, Surrey, United Kingdom · Recruiting
University College London Hospitals
London, UK, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.